The best indicator for Lilly (Eli) (LLY)
We backtested 20 indicators across daily, weekly and hourly charts on real Lilly (Eli) (LLY) history. Here's what actually worked — risk-adjusted, out-of-sample, with costs.
WaveTrend (8/6/4)
On the daily chart, this is the strongest risk-adjusted edge we found for Lilly (Eli) (LLY) over ~54.0 years — trailing buy-and-hold by 4.7% CAGR.
The winner on each chart
Every indicator, ranked
Ranked by Sharpe (risk-adjusted return). Hypothetical, fees included.
| # | Indicator | TF | CAGR | Sharpe | Max DD | Win | Trades | vs B&H |
|---|---|---|---|---|---|---|---|---|
| 1 | WaveTrend (8/6/4) ✓ | Daily | 9.5% | 0.56 | -56.8% | 73.8% | 214 | -4.7% |
| 2 | CCI ✓ | Daily | 8.1% | 0.53 | -52.9% | 70.9% | 261 | -6.1% |
| 3 | EMA 20/50 Cross ✓ | Weekly | 9.6% | 0.52 | -60.9% | 50.0% | 28 | -4.5% |
| 4 | Williams %R ✓ | Daily | 7.5% | 0.5 | -64.2% | 70.6% | 354 | -6.7% |
| 5 | EMA 50/200 Cross ✓ | Daily | 8.0% | 0.46 | -71.1% | 26.2% | 42 | -6.1% |
| 6 | Money Flow Index ✓ | Daily | 6.7% | 0.46 | -52.4% | 81.7% | 60 | -7.4% |
| 7 | SMA 50/200 Cross ✓ | Daily | 7.4% | 0.44 | -67.9% | 47.6% | 42 | -6.8% |
| 8 | Stochastic ✓ | Daily | 6.2% | 0.44 | -60.2% | 68.1% | 279 | -7.9% |
| 9 | Bollinger Mean-Reversion ✓ | Weekly | 4.8% | 0.43 | -34.1% | 81.8% | 44 | -9.2% |
| 10 | Williams %R ✓ | Weekly | 5.8% | 0.43 | -44.1% | 82.4% | 74 | -8.2% |
| 11 | Bollinger Mean-Reversion ✓ | Daily | 5.3% | 0.42 | -53.6% | 70.5% | 227 | -8.8% |
| 12 | Holy Grail Confluence ✓ | Daily | 5.5% | 0.42 | -32.4% | 73.2% | 82 | -8.6% |
| 13 | Donchian Breakout ✓ | Weekly | 6.4% | 0.42 | -68.2% | 39.1% | 46 | -7.7% |
| 14 | ADX / DMI ✓ | Weekly | 5.6% | 0.41 | -64.5% | 45.9% | 61 | -8.5% |
✓ = held up out-of-sample. Hypothetical, costs included. See methodology.
For Lilly (Eli) (LLY), WaveTrend (8/6/4) on the daily timeframe gave the best balance of return and risk in our test. It still trailed buy-and-hold on raw return — but remember: this is a hypothetical backtest of a standard rule, not a recommendation. Markets change. See the methodology and disclaimer.
More stock
Get the weekly edge report
The best-performing indicator per asset, what changed this week, and the honest caveats — straight to your inbox.